medigraphic.com

2008, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2008; 46 (3)

Respiratory Tract Fluid Microbiology in a Care Intensive Unit

Casanova-Cardiel LJ, Castañón-González JA, León-Gutiérrez MA, Becerra-Lara JJ, Calyeca-Sánchez MV, Franco-Contreras AE, Polanco-Flores E, González-Green I, Martínez-Gutiérrez M

Language: Spanish
References: 45
Page: 329-338
PDF size: 223.10 Kb.


ABSTRACT

Objective: to know patterns of antimicrobial resistance of bacterial isolates from tracheal aspirates in an Intensive Care Unit and to evaluate the cases of ventilator-associated pneumonia.
Methods: antibiotic sensitivity test was done. A comparison was made between patients with nosocomial pneumonia reported by infection surveillance team against those reported by the attending physician with the infectious disease consultant.
Results: Pseudomonas aeruginosa was the bacteria most frequently reported with 134 isolates (26 %), 71 were multiple-drug-resistant; followed by Staphylococcus with 122 isolates (24 %), of which 88 were S. aureus with 62 of them (70 %) methicillin-resistant. Enterobacteriaceae, E. coli, K. pneumoniae, E. cloacae, S. marcescens, as well as Acinetobacter sp. and S. maltophilia were occasionally isolated. Candida represented 17 % of the isolates. Three peaks of isolates of S. aureus and P. aeruginosa were identified during the two years of surveillance. There were differences in cases of ventilator associated pneumonia reported by the hospital based epidemiology team and the attending clinicians in collaboration with an Infectious disease consultant.
Conclusions: prevalence of Multiple-drugresistant Pseudomonas aeruginosa (53 %) and methicillin resistant Staphylococcus (70 %) isolated from the airway is high in our Intensive Care Unit. Enterobacterias, Acinetobacter sp. and Stenotrophomonas maltophilia colonization are low in our Intensive Care Unit.


REFERENCES

  1. Johanson W, Pierce A, Sanford J, Thomas GD. Nosocomial respiratory infections with gramnegative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 1972; 77(5):701-706.

  2. Ewig S, Torres A, El-Ebiary M, Fábregas N, Hernández C, González J, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Am J Respir Crit Care Med 1999(1);159:188-98.

  3. Rello J, Sonora R, Jubert P, Artigas A, Rue M, Valles J. Pneumonia in intubated patients: role of respiratory airway care. Am J Respir Crit Care Med 1996; 154(1):111-115.

  4. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites. Implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999;160:608-613.

  5. Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator-associated pneumonia. Chest 2006; 130:597-604

  6. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171(4):388-416.

  7. Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: general principles and contemporary practices. Clin Infect Dis 1998;26: 973-978.

  8. Rello J, Paiva JA, Baraibar J, Barcenilla F, Bodi M, Castander D, et al. International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest 2001;120(3):955-970.

  9. Dirección de Prestaciones Médicas, Coordinación de Salud Pública. Manual para la vigilancia epidemiológica, prevalencia y control de las infecciones nosocomiales. México: IMSS; 2004. Disponible en http://www.imss.gob.mx/dpm/dties/produc/Normatividad/Manuales/SCDo_15.Pdf

  10. Meyer E, Schwab F, Gastmeier P, Jonas D, Rueden H, Daschner FD. Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: Data from Project SARI (Surveillance of Antimicrobials Use and Antimicrobial Resistance in Intensive Care Units). Infect Control Hosp Epidemiol 2006;27(2):146-154.

  11. Haddadin AS, Fappiano SA, Lipsett PA. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J 2002;78(921): 385-392.

  12. Klevens RM, Edwards RJ, Tenover FC, McDonald LC, Horan T, Gayness R. National nosocomial infections surveillance system. Clin Infect Dis 2006;42(3):389-391.

  13. Casanova-Cardiel LJ, Castañón-González JA. Reflexiones acerca del lavado de manos. Rev Med IMSS 2004;42(6):519-524.

  14. Zahar JR, Clec’h C, Garrouste-Orgeas M, Jamali S, Mourvillier B, De Lassence A, et al. Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia? Clin Infect Dis 2005;41(9):1224-1231.

  15. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2003;36(1):53-59.

  16. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteriemia: a meta-analysis. Med J Aust 2001;175 (5):264-267.

  17. Patterson JE, Sweeney AH, Simms M, Carley N, Mangi R, Sabetla J, et al. An analysis of 110 serious enterococcal infections; epidemiology, antibiotic susceptibility, and outcomes. Medicine 1995;74(9):191-200.

  18. Streit JM, Jones RN, Sader HS, Fritsche TR. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 2004;24(2):111-118.

  19. Bauer TT. Nosocomial pneumonia. Therapy is just not good enough. Chest 2003;124(5):1632-1634.

  20. Wunderink RG, Rello J, Cammarata SK, Cross-Dabrera RV, Kollef MH. Linezolid vs. vancomycin. Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003;124(5):1789-1797.

  21. Yamazumi T, Marshall SA, Wilke WW, Diekema DJ, Pfaller MA, Jones RN. Comparison of the Vitek gram-positive susceptibility 106 card and the MRSAscreen latex agglutination test for determining oxacillin resistant in clinical bloodstream isolates of Staphylococcus aureus. J Clin Microbiol 2001; 39(1);53-56.

  22. Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991;29(10):2240-2244.

  23. Tokue Y, Shoji S, Satoh K, Watanabe A, Motomiya M. Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1992;36(1) 6-9.

  24. Ubukata K, Nakagami S, Nitta A, Yamane A, Kawakami S, Sugiura M, et al. Rapid detection of the mecA gene in methicillin-resistant staphylococci by enzymatic detection of polymerase chain reaction products. J Clin Microbiol 1992;30(7): 1728-1733.

  25. Plant PK, Owen JL, Elliott MW. Early use of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicenter randomized controlled trial. Lancet 2000; 355 (9219): 1931-1935.

  26. Masip J, Betbese AJ, Paez J, Vecilla F, Canizares R, Padro J, et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary edema: a randomized trial. Lancet 2000;356(9248):2126-2132.

  27. Nourdine K, Combes P, Carton MJ, Beuret P, Cannamela A, Deureux JC, et al. Does non-invasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med 1999;25(6):567-573.

  28. Nava S, Ambrosino N, Clini E, Prato M, Orlando G, Vitacca M, et al. Non invasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease: a randomized, controlled trial. Ann Intern Med 1998;128(9):721-728.

  29. Ferrer M, Esquinas A, Arancibia F, Bauer TT, González G, Carrillo A, et al. Non invasive mechanical ventilation for persistent weaning failure: a randomized controlled trial. Am J Respir Crit Care Med 2003;168(1):70-76.

  30. Rubinstein E, Cammarata SK, Oliphant TH, Wunderink RG. Linezolid Nosocomial Pneumonia Study Group. Linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 2001;32(3):402-142.

  31. Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH, Linezolid Nosocomial Pneumonia Study Group. Linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia: continuation of a randomized, double-blind multicenter study. Clin Ther 2003;25(3):980-992.

  32. Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2002;34(11):1481-1490.

  33. Van Eldere JJ. Microbiology and the diagnosis and treatment of ventilator-associated pneumonia. Rev Med Microbiol 2004;15(4):119-128.

  34. Gruson D, Guilles H, Vargas F, Valentino R, Bui N, Pereyre S, et al. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilatorassociated pneumonia. Crit Care Med 2003;31(7): 1908-1914.

  35. Fabregas N, Ewig S, Torres A, El-Ebiary M, Ramírez J, de la Bellacasa JP, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999;54(10):867-873.

  36. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002;34(1 March): 634-640.

  37. Arruda EAG, Marinho IS, Boulos M, Sinto SI, Caiaffa HH, Mendes CM, et al. Nosocomial infections caused by multiresistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 1999;20(9):620-623.

  38. Chastre J. Infections due to Acinetobacter baumannii in the ICU. Seminars Resp Crit Car Med 2003; 24(1):69-77.

  39. Wachter K. Move over, MRSA: tough Acinetobacter threatens hospitals. Nosocomial superbug infections climb. Chest Physician 2006;1(1):1 and 4.

  40. Murray CK, Hospenthal DR. Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis 2005;18:502-506.

  41. Sanyal SC, Mokaddas EM. The increase in carbapenem use and emergence of Stenotrophomona maltophilia as an important nosocomial pathogen. J Chemother 1999;11(1):28-33.

  42. Kollef MH, Sherman G, Ward S. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-474.

  43. Rello J, Esandi ME, Díaz E, Mariscal D, Gallego M, Valles J. The role of Candida sp. isolated from bronchoscopic simples in nonneutropenic patients. Chest 1998;114(1):146-149.

  44. El-Ebiary M, Torres A, Fabregas A, de la Bellacasa JP, González J, Ramírez J, et al. Significance of the isolation of Candida species from respiratory simples in critically ill, non-neutropenic patients: an immediate postmortem histologic study. Am J Respir Crit Care Med 1997;156(2 Pt 1):583-590.

  45. Casanova-Cardiel LJ. Consideraciones acerca de brotes nosocomiales. Med Int Mex 2004;20:140-143.




2020     |     www.medigraphic.com